Comparison between Krsnaa Diagnostics IPO and Windlas Biotech IPO.
Krsnaa Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Krsnaa Diagnostics IPO is up to ₹1,213.33 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Krsnaa Diagnostics IPO is ₹954.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
| Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹5 per share |
| Issue Price (Lower) | ₹933.00 per share | ₹448.00 per share |
| Issue Price (Upper) | ₹954.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹954.00 per share | ₹460.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹93.00 per share | |
| Market Lot Size | 15 shares | 30 shares |
| Fresh Issue Size | 42,06,085 shares | 35,86,956 shares |
| Fresh Issue Size (Amount) | up to ₹400.84 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 85,25,520 shares | 51,42,067 shares |
| OFS Issue Size (Amount) | up to ₹812.49 Cr | up to ₹236.54 Cr |
| Issue Size Total | 1,27,31,605 shares | 87,29,023 shares |
| Issue Size Total (Amount) | up to ₹1,213.33 Cr | up to ₹401.54 Cr |
Krsnaa Diagnostics IPO opens on Aug 04, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Krsnaa Diagnostics IPO and Windlas Biotech IPO is Aug 06, 2021, and Aug 06, 2021, respectively.
| Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2021 | Aug 03, 2021 |
| Issue Open | Aug 04, 2021 | Aug 04, 2021 |
| Issue Close | Aug 06, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Aug 11, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Aug 12, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Aug 13, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Aug 16, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Sep 10, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Nov 09, 2021 | Nov 09, 2021 |
Krsnaa Diagnostics IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
| Krsnaa Diagnostics IPO | Windlas Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 31.62 | 78 | ||||
| Promoter Shareholding (Post-Issue) | 27.38 | 65.16 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2996.23 Cr. | ₹1002.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Krsnaa Diagnostics IPO Retail Individual Investors (RII) are offered 12,50,874 shares while in Windlas Biotech IPO retail investors are offered 12,50,874 shares. Qualified Institutional Buyers (QIB) are offered 37,52,625 shares in Krsnaa Diagnostics IPO and 17,45,804 shares in Windlas Biotech IPO.
| Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,28,937 shares | 26,18,706 shares |
| Market Maker Reservation | ||
| QIB | 37,52,625 shares | 17,45,804 shares |
| NII | 18,76,312 shares | 13,09,354 shares |
| RII | 12,50,874 shares | 30,55,159 shares |
| Employee | 2,32,288 shares | |
| Others | ||
| Total | 1,27,41,036 shares | 87,29,023 shares |
Krsnaa Diagnostics IPO subscribed 64.38x in total, whereas Windlas Biotech IPO subscribed 22.44x.
| Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
|---|---|---|
| QIB (times) | 49.83x | 24.40x |
| NII (times) | 116.30x | 15.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 41.95x | 24.22x |
| Employee (times) | 0.98x | |
| Other (times) | ||
| Total (times) | 64.38x | 22.44x |
